Ignite Creation Date:
2025-12-26 @ 12:18 PM
Ignite Modification Date:
2026-02-05 @ 5:31 PM
Study NCT ID:
NCT00975000
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2009-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
Sponsor:
Amgen
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Allograft Nephropathy | View |
| None | Chronic Kidney Disease | View |
| None | Chronic Renal Failure | View |
| None | Disordered Mineral Metabolism | View |
| None | End Stage Renal Disease | View |
| None | Hyperparathyroidism | View |
| None | Hypophosphatemia | View |
| None | Kidney Disease | View |
| None | Kidney Transplantation | View |
| None | Post Renal Transplantation | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Intervention | View |
| None | Cinacalcet | View |
| None | Sensipar | View |
| None | Mimpara | View |
| None | hyperparathyroidism | View |
| None | calcium | View |
| None | osteodystrophy | View |
| None | hypercalcemia | View |
| None | renal | View |
| None | transplant | View |
| None | acute rejection | View |
| None | kidney transplant failure | View |
| None | hypophosphatemia | View |